Oruka Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview

Oruka Therapeutics

28/01/2025 21:09

* Oruka Therapeutics Inc  ORKA.OQ   ORKA.O  is expected
to report
resultson January 30 (estimated) for the period ending December
31 2024
    * 
    * ​LSEG's mean analyst estimate for Oruka Therapeutics Inc
is for
a loss of 68 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Oruka
Therapeutics Inc is $42.50​, above​ its last closing price
of $11.44. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.53       -0.40      -1.46     Missed  -263.3
  2024                                                  
                                                        ​
 ​​                                                     
                                                        ​
 This summary was machine generated January 28 at 21:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)